01.28.11
Susan Schniepp, vice president of quality at OSO BioPharmaceuticals Manufacturing, LLC, has been elected to the board of directors at the Parenteral Drug Association (PDA). Her term on the board of directors is for two years.
Ms. Schniepp has served on numerous PDA committees and was a featured speaker at events. She received PDA’s Distinguished Author Award for her book, Understanding the United States Pharmacopeia and the National Formulary: Demystifying the Standards-Setting Process, as well as the Distinguished Service Award in 2008 and the Gordon Personeus Award in 2010, honoring her contributions to the organization.
“Sue is a shining star within our industry for her unflagging commitment to high quality and her willingness to share her knowledge and experience with others,” said Stuart Rose, president and chief executive officer of OsoBio. “Serving on the PDA board affords Susan yet another opportunity to spread the quality message and lead by example.”
At OsoBio, Ms. Schniepp is responsible managing all operational quality-related issues for cGMP compliance of facilities. She is also responsible for regulatory affairs, records and filings.
Click here to learn more about OSO BioPharmaceuticals
Ms. Schniepp has served on numerous PDA committees and was a featured speaker at events. She received PDA’s Distinguished Author Award for her book, Understanding the United States Pharmacopeia and the National Formulary: Demystifying the Standards-Setting Process, as well as the Distinguished Service Award in 2008 and the Gordon Personeus Award in 2010, honoring her contributions to the organization.
“Sue is a shining star within our industry for her unflagging commitment to high quality and her willingness to share her knowledge and experience with others,” said Stuart Rose, president and chief executive officer of OsoBio. “Serving on the PDA board affords Susan yet another opportunity to spread the quality message and lead by example.”
At OsoBio, Ms. Schniepp is responsible managing all operational quality-related issues for cGMP compliance of facilities. She is also responsible for regulatory affairs, records and filings.
Click here to learn more about OSO BioPharmaceuticals